AstraZeneca, Merck and Novo Nordisk deals boost Chinese biotech sector
Recent pharmaceutical deals involving AstraZeneca, Merck, and Novo Nordisk have bolstered global investor confidence in Chinese biotech innovation.
Recent pharmaceutical deals involving AstraZeneca, Merck, and Novo Nordisk have bolstered global investor confidence in Chinese biotech innovation.